REMEGEN CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.25 HKD | -3.04% |
|
-5.32% | -19.23% |
| 04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
e9c44ce7fc5f64d31043.0-hjtx2_aT_rJRuhPfAu0QlbqfMsvOzIA7rU6Ea3rTI.oas2wEzyB1WRS03rbLgDpiQM7pBd8tqYa_vlriH29UCfrTGEX8lYV71raA~82a883999c473c03e043988fb7a51e0b